Transgene Pink Sheet Forecast - Accumulation Distribution

TRGNF Stock  USD 1.59  0.00  0.00%   
Transgene Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Transgene's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
On November 21, 2024 Transgene SA had Accumulation Distribution of 0. The accumulation distribution (A/D) indicator shows the degree to which Transgene is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Transgene SA to determine if accumulation or reduction is taking place in the market. This value is adjusted by Transgene trading volume to give more weight to distributions with higher volume over lower volume.
Check Transgene VolatilityBacktest TransgeneTrend Details  

Transgene Trading Date Momentum

On November 22 2024 Transgene SA was traded for  1.59  at the closing time. The highest daily price throughout the period was 1.59  and the lowest price was  1.59 . There was no trading activity during the period 1.0. Lack of trading volume on 11/22/2024 did not result in any price rise and fall. The trading price change to current closing price is 0.00% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Transgene to competition

Other Forecasting Options for Transgene

For every potential investor in Transgene, whether a beginner or expert, Transgene's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Transgene Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Transgene. Basic forecasting techniques help filter out the noise by identifying Transgene's price trends.

Transgene Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Transgene pink sheet to make a market-neutral strategy. Peer analysis of Transgene could also be used in its relative valuation, which is a method of valuing Transgene by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Transgene SA Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Transgene's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Transgene's current price.

Transgene Market Strength Events

Market strength indicators help investors to evaluate how Transgene pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Transgene shares will generate the highest return on investment. By undertsting and applying Transgene pink sheet market strength indicators, traders can identify Transgene SA entry and exit signals to maximize returns.

Currently Active Assets on Macroaxis

Other Information on Investing in Transgene Pink Sheet

Transgene financial ratios help investors to determine whether Transgene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Transgene with respect to the benefits of owning Transgene security.